Treatment of lupus using humanized anti-CXCR5 antibodies

• 收藏
• 分享

专利权人:

Sanofi

发明人:

Ming, Jeffrey,Zilberstein, Moshe E.,Karimi Anderesi, Roghieh

申请号：

AU2018238540

公开号：

AU2018238540A1

申请日:

2018.03.22

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

This disclosure provides anti-CXCR5 antibodies and their use in the amelioration, treatment, or prevention of lupus. The disclosure also provides prophylactic, immunotherapeutic, and diagnostic compositions comprising an anti-CXCR5 antibody, and the use of such anti-CXCR5 antibodies in methods of preventing or treating lupus in mammals, including humans.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/